These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 24698146)
21. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique. Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816 [TBL] [Abstract][Full Text] [Related]
22. A protein/antibiotic releasing poly(lactic-co-glycolic acid)/lecithin scaffold for bone repair applications. Shi X; Wang Y; Ren L; Huang W; Wang DA Int J Pharm; 2009 May; 373(1-2):85-92. PubMed ID: 19429292 [TBL] [Abstract][Full Text] [Related]
23. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions. Liu SQ; Tong YW; Yang YY Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542 [TBL] [Abstract][Full Text] [Related]
24. In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold. Zhu XH; Wang CH; Tong YW J Biomed Mater Res A; 2009 May; 89(2):411-23. PubMed ID: 18431776 [TBL] [Abstract][Full Text] [Related]
25. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters. Chaisri W; Ghassemi AH; Hennink WE; Okonogi S Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499 [TBL] [Abstract][Full Text] [Related]
26. Release optimization of epidermal growth factor from PLGA microparticles. Mirdailami O; Khoshayand MR; Soleimani M; Dinarvand R; Atyabi F Pharm Dev Technol; 2014 Aug; 19(5):539-47. PubMed ID: 23777385 [TBL] [Abstract][Full Text] [Related]
27. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres. Janoria KG; Mitra AK Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204 [TBL] [Abstract][Full Text] [Related]
28. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine. Bae SE; Son JS; Park K; Han DK J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089 [TBL] [Abstract][Full Text] [Related]
29. Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery. Lee J; Oh YJ; Lee SK; Lee KY J Control Release; 2010 Aug; 146(1):61-7. PubMed ID: 20553775 [TBL] [Abstract][Full Text] [Related]
30. Mucosal or systemic administration of rE2 glycoprotein antigen loaded PLGA microspheres. Brandhonneur N; Loizel C; Chevanne F; Wakeley P; Jestin A; Le Potier MF; Le Corre P Int J Pharm; 2009 May; 373(1-2):16-23. PubMed ID: 19429284 [TBL] [Abstract][Full Text] [Related]
31. The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles. Samadi N; Abbadessa A; Di Stefano A; van Nostrum CF; Vermonden T; Rahimian S; Teunissen EA; van Steenbergen MJ; Amidi M; Hennink WE J Control Release; 2013 Dec; 172(2):436-43. PubMed ID: 23751568 [TBL] [Abstract][Full Text] [Related]
32. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method. Leo E; Pecquet S; Rojas J; Couvreur P; Fattal E J Microencapsul; 1998; 15(4):421-30. PubMed ID: 9651864 [TBL] [Abstract][Full Text] [Related]
33. Double-walled microspheres loaded with meglumine antimoniate: preparation, characterization and in vitro release study. Navaei A; Rasoolian M; Momeni A; Emami S; Rafienia M Drug Dev Ind Pharm; 2014 Jun; 40(6):701-10. PubMed ID: 23594302 [TBL] [Abstract][Full Text] [Related]
34. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. Díez S; Tros de Ilarduya C Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172 [TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery. Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438 [TBL] [Abstract][Full Text] [Related]
36. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Dong Y; Feng SS Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372 [TBL] [Abstract][Full Text] [Related]
37. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin. Lane ME; Brennan FS; Corrigan OI Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944 [TBL] [Abstract][Full Text] [Related]
38. Preparation of protein-loaded sustained-release microspheres via 'solid-in-oil-in-hydrophilic oil-in-ethanol (S/O/hO/E)' emulsification. Yuan W; Zhang Y; Wu F; Li H; Cai Y; Zhang Y; Han M; Jin T Colloids Surf B Biointerfaces; 2010 Sep; 79(2):326-33. PubMed ID: 20483570 [TBL] [Abstract][Full Text] [Related]
39. PLGA/polymeric liposome for targeted drug and gene co-delivery. Wang H; Zhao P; Su W; Wang S; Liao Z; Niu R; Chang J Biomaterials; 2010 Nov; 31(33):8741-8. PubMed ID: 20727587 [TBL] [Abstract][Full Text] [Related]
40. The effect of glycolic acid monomer ratio on the emulsifying activity of PLGA in preparation of protein-loaded SLN. Xie S; Wang S; Zhu L; Wang F; Zhou W Colloids Surf B Biointerfaces; 2009 Nov; 74(1):358-61. PubMed ID: 19717285 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]